Abeona Therapeutics Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported revenue was USD 3 million compared to USD 10 million a year ago. Net loss was USD 84.94 million compared to USD 84.23 million a year ago.

Basic loss per share from continuing operations was USD 21.5 compared to USD 22.75 a year ago.